public healthIdeasGrowth Teams Have the Tools to Be Covid Anti-Growth TeamsBy Aza RaskinSecurityIndia's Contact Tracing App Could Leak Patient LocationsBy Andy GreenbergScienceThe H1N1 Crisis Predicted Covid-19’s Toll on Black AmericansBy Sidney FussellScienceEverything We Know About Covid-19 Antibody Tests (So Far)By Matt JancerScienceThe FDA Tightens the Rules for Covid-19 Antibody Blood TestsBy Gregory BarberScienceHow Might the Change of Seasons Affect Covid-19?By Maryn McKennaIdeasA Prophet of Scientific Rigor—and a Covid ContrarianBy David H. FreedmanIdeasThe Dire Diplomacy of the Global 'Race for a Vaccine'By Brendan BorrellScienceMicrobe Mappers Are Tracking Covid-19's Invisible TracesBy Megan MolteniScienceCovid-19 Was Here Earlier Than Previously Thought. Now What?By Gregory BarberIdeasStop Getting So Excited About ‘Preliminary’ FindingsBy Christie AschwandenScienceHow Argentina’s Strict Covid-19 Lockdown Saved LivesBy Megan MolteniTransportationDrones Take Flight to Carry Covid-19 Tests to Labs in AfricaBy Alex DaviesIdeasAnti-Quarantine Protests Are Dangerous and WeirdBy Whitney PhillipsScience‘Covid Near You’ Crowdsources Data to Predict New Hot Spots By Maryn McKennaScienceThe Cold, Hard Work of Delivering Oxygen to VentilatorsBy Alex DaviesBusinessInstacart Workers Are Still Waiting for Those Safety SuppliesBy Arielle PardesScienceThe Magical Thinking of the White House’s New Covid-19 PlanBy Adam RogersIdeasCovid-19 Does Not Discriminate by Body WeightBy Christy HarrisonThe Big Story‘Everybody and His Dog Is Trying to Sell Medical Equipment’By Mara HvistendahlSecurityApple and Google Respond to Covid-19 Contact Tracing ConcernsBy Andy GreenbergScienceState Alliances Are Leading the US Fight Against Covid-19By Adam RogersIdeasTrump Voters Aren't Staying In As Much As Everybody ElseBy Gilad EdelmanScienceWhat if Covid-19 Returns Every Year, Like the Common Cold?By Gregory BarberMore Stories
